首页 > 最新文献

Journal of Gastroenterology and Hepatology最新文献

英文 中文
Prevalence and Incidence of Peutz-Jeghers Syndrome and Juvenile Polyposis Syndrome in Japan: A Nationwide Epidemiological Survey in 2022. 日本peutz - jegers综合征和青少年息肉病综合征的患病率和发病率:2022年全国流行病学调查
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-02 DOI: 10.1111/jgh.16839
Yuri Matsubara, Yosikazu Nakamura, Yoshiko Nakayama, Tomonori Yano, Hideki Ishikawa, Hideki Kumagai, Junji Umeno, Keiichi Uchida, Keisuke Jimbo, Toshiki Yamamoto, Hideyuki Ishida, Okihide Suzuki, Koichi Okamoto, Fumihiko Kakuta, Yuhki Koike, Yuko Kawasaki, Hirotsugu Sakamoto

Background and aim: Peutz-Jeghers syndrome (PJS) and juvenile polyposis syndrome (JPS) are autosomal dominant diseases associated with high cancer risk. In Japan, knowledge about the prevalence and incidence of PJS and JPS is lacking despite being crucial for providing appropriate medical support. We aimed to determine the prevalence and incidence of these diseases.

Methods: In 2022, a nationwide questionnaire survey was conducted to determine the number of patients with PJS or JPS by sex and the number of newly confirmed cases from 2019 to 2021. The target facilities included gastroenterology, pediatrics, and pediatric surgery departments, which were stratified into seven classes on the basis of the total number of beds. We randomly selected target facilities using different extraction rates in each class, resulting in 1748/2912 facilities (extraction rate: 60%) as the final sample. We calculated the estimated number of patients using the response and extraction rates.

Results: A total of 1077 facilities responded to the survey. The estimated numbers of patients with PJS and JPS were 701 (95% confidence interval [CI]: 581-820) and 188 (95% CI: 147-230), respectively. The 3-year period prevalences of PJS and JPS were 0.6/100000 and 0.15/100000, whereas the incidences in 2021 were 0.07/100000 and 0.02/100000, respectively. Male patients constituted 53.5% and 59.6% in the PJS and JPS groups, respectively.

Conclusions: We determined the prevalence and incidence of PJS and JPS in Japan for the first time. Further research is needed to obtain more detailed information, including the clinical differences and outcomes in Japan.

背景与目的:Peutz-Jeghers综合征(PJS)和青少年息肉病综合征(JPS)是常染色体显性遗传病,具有较高的癌症风险。在日本,关于PJS和JPS的患病率和发病率的知识缺乏,尽管这对提供适当的医疗支持至关重要。我们的目的是确定这些疾病的患病率和发病率。方法:于2022年在全国范围内进行问卷调查,确定2019 - 2021年PJS或JPS患者按性别分列的人数和新确诊病例数。目标设施包括消化内科、儿科和儿科外科,根据床位总数分为7类。我们在每个类别中随机选择不同提取率的目标设施,最终样本为1748/2912个设施(提取率为60%)。我们使用应答率和提取率来计算估计的患者数量。结果:共有1077家设施参与了调查。PJS和JPS患者的估计数量分别为701例(95%可信区间[CI]: 581-820)和188例(95% CI: 147-230)。PJS和JPS 3年患病率分别为0.6/100000和0.15/100000,2021年患病率分别为0.07/100000和0.02/100000。PJS组男性占53.5%,JPS组男性占59.6%。结论:我们首次确定了PJS和JPS在日本的患病率和发病率。需要进一步的研究来获得更详细的信息,包括在日本的临床差异和结果。
{"title":"Prevalence and Incidence of Peutz-Jeghers Syndrome and Juvenile Polyposis Syndrome in Japan: A Nationwide Epidemiological Survey in 2022.","authors":"Yuri Matsubara, Yosikazu Nakamura, Yoshiko Nakayama, Tomonori Yano, Hideki Ishikawa, Hideki Kumagai, Junji Umeno, Keiichi Uchida, Keisuke Jimbo, Toshiki Yamamoto, Hideyuki Ishida, Okihide Suzuki, Koichi Okamoto, Fumihiko Kakuta, Yuhki Koike, Yuko Kawasaki, Hirotsugu Sakamoto","doi":"10.1111/jgh.16839","DOIUrl":"https://doi.org/10.1111/jgh.16839","url":null,"abstract":"<p><strong>Background and aim: </strong>Peutz-Jeghers syndrome (PJS) and juvenile polyposis syndrome (JPS) are autosomal dominant diseases associated with high cancer risk. In Japan, knowledge about the prevalence and incidence of PJS and JPS is lacking despite being crucial for providing appropriate medical support. We aimed to determine the prevalence and incidence of these diseases.</p><p><strong>Methods: </strong>In 2022, a nationwide questionnaire survey was conducted to determine the number of patients with PJS or JPS by sex and the number of newly confirmed cases from 2019 to 2021. The target facilities included gastroenterology, pediatrics, and pediatric surgery departments, which were stratified into seven classes on the basis of the total number of beds. We randomly selected target facilities using different extraction rates in each class, resulting in 1748/2912 facilities (extraction rate: 60%) as the final sample. We calculated the estimated number of patients using the response and extraction rates.</p><p><strong>Results: </strong>A total of 1077 facilities responded to the survey. The estimated numbers of patients with PJS and JPS were 701 (95% confidence interval [CI]: 581-820) and 188 (95% CI: 147-230), respectively. The 3-year period prevalences of PJS and JPS were 0.6/100000 and 0.15/100000, whereas the incidences in 2021 were 0.07/100000 and 0.02/100000, respectively. Male patients constituted 53.5% and 59.6% in the PJS and JPS groups, respectively.</p><p><strong>Conclusions: </strong>We determined the prevalence and incidence of PJS and JPS in Japan for the first time. Further research is needed to obtain more detailed information, including the clinical differences and outcomes in Japan.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonlesional ileal transcriptome in Crohn's disease reveals alterations in immune response and metabolic pathway. 克罗恩病非单节回肠转录组揭示了免疫反应和代谢途径的改变。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-27 DOI: 10.1111/jgh.16816
Ho-Su Lee, Yoonho Lee, Jiwon Baek, Yongjae Kim, Sojung Park, Seulgi Jung, Jong Geol Lee, In-Jeoung Baek, Kyuwon Kim, Sung Wook Hwang, Jong Lyul Lee, Sang Hyoung Park, Suk-Kyun Yang, Buhm Han, Kyuyoung Song, Yong Sik Yoon, Byong Duk Ye

Background and aim: We aimed to assess the gene expression profiles of nonlesional small bowels in patients with Crohn's disease (CD) to identify its accompanying molecular alterations.

Methods: We performed RNA sequencing of the uninflamed small bowel tissues obtained from 70 patients with ileal CD and 9 patients with colon cancer (non-CD controls) during bowel resection. Differentially expressed gene (DEG) analyses were performed using DESeq2. Gene set enrichment, correlation, and cell deconvolution analyses were applied to identify modules and functionally enriched transcriptional signatures of CD.

Results: A comparison of CD patients and non-CD controls revealed that of the 372 DEGs, 49 protein-coding genes and 5 long non-coding RNAs overlapped with the inflammatory bowel disease susceptibility loci. The pathways related to immune and inflammatory reactions were upregulated in CD, while metabolic pathways were downregulated in CD. Compared with non-CD controls, CD patients had significantly higher proportions of immune cells, including plasma cells (P = 1.15 × 10-4), and a lower proportion of epithelial cells (P = 1.12 × 10-4). Co-upregulated genes (M14 module) and co-downregulated genes (M9 module) were identified in CD patients. The M14 module was enriched in immune-related genes and significantly associated with the responses to anti-tumor necrosis factor (TNF) therapy. The core signature of the M14 module was comprised of six genes and was upregulated in nonresponders to anti-TNF therapy of five independent cohorts (n = 163), indicating acceptable discrimination ability (area under the receiver operating characteristic curve of 75-86%).

Conclusions: The differences in gene expression and cellular composition between CD patients and non-CD controls imply significant molecular alterations, which are associated with the response to anti-TNF treatment.

背景和目的:我们旨在评估克罗恩病(CD)患者非发炎小肠的基因表达谱,以确定其伴随的分子改变:我们对从 70 名回肠 CD 患者和 9 名结肠癌患者(非 CD 对照组)肠切除术中获得的未发炎小肠组织进行了 RNA 测序。使用 DESeq2 对差异表达基因(DEG)进行了分析。应用基因组富集、相关性和细胞去卷积分析确定了CD的模块和功能富集转录特征:结果:对 CD 患者和非 CD 对照组进行比较后发现,在 372 个 DEGs 中,49 个蛋白编码基因和 5 个长非编码 RNA 与炎症性肠病易感基因位点重叠。与免疫和炎症反应相关的通路在 CD 中上调,而代谢通路在 CD 中下调。与非 CD 对照组相比,CD 患者的免疫细胞(包括浆细胞)比例明显较高(P = 1.15 × 10-4),而上皮细胞比例较低(P = 1.12 × 10-4)。在 CD 患者中发现了共上调基因(M14 模块)和共下调基因(M9 模块)。M14模块富含免疫相关基因,与抗肿瘤坏死因子(TNF)治疗反应显著相关。M14模块的核心特征由6个基因组成,在5个独立队列(n = 163)的抗肿瘤坏死因子治疗无应答者中上调,显示了可接受的鉴别能力(接收者操作特征曲线下面积为75-86%):结论:CD患者和非CD对照组之间在基因表达和细胞组成方面的差异意味着存在重大的分子改变,这与抗肿瘤坏死因子治疗的反应有关。
{"title":"Nonlesional ileal transcriptome in Crohn's disease reveals alterations in immune response and metabolic pathway.","authors":"Ho-Su Lee, Yoonho Lee, Jiwon Baek, Yongjae Kim, Sojung Park, Seulgi Jung, Jong Geol Lee, In-Jeoung Baek, Kyuwon Kim, Sung Wook Hwang, Jong Lyul Lee, Sang Hyoung Park, Suk-Kyun Yang, Buhm Han, Kyuyoung Song, Yong Sik Yoon, Byong Duk Ye","doi":"10.1111/jgh.16816","DOIUrl":"https://doi.org/10.1111/jgh.16816","url":null,"abstract":"<p><strong>Background and aim: </strong>We aimed to assess the gene expression profiles of nonlesional small bowels in patients with Crohn's disease (CD) to identify its accompanying molecular alterations.</p><p><strong>Methods: </strong>We performed RNA sequencing of the uninflamed small bowel tissues obtained from 70 patients with ileal CD and 9 patients with colon cancer (non-CD controls) during bowel resection. Differentially expressed gene (DEG) analyses were performed using DESeq2. Gene set enrichment, correlation, and cell deconvolution analyses were applied to identify modules and functionally enriched transcriptional signatures of CD.</p><p><strong>Results: </strong>A comparison of CD patients and non-CD controls revealed that of the 372 DEGs, 49 protein-coding genes and 5 long non-coding RNAs overlapped with the inflammatory bowel disease susceptibility loci. The pathways related to immune and inflammatory reactions were upregulated in CD, while metabolic pathways were downregulated in CD. Compared with non-CD controls, CD patients had significantly higher proportions of immune cells, including plasma cells (P = 1.15 × 10<sup>-4</sup>), and a lower proportion of epithelial cells (P = 1.12 × 10<sup>-4</sup>). Co-upregulated genes (M14 module) and co-downregulated genes (M9 module) were identified in CD patients. The M14 module was enriched in immune-related genes and significantly associated with the responses to anti-tumor necrosis factor (TNF) therapy. The core signature of the M14 module was comprised of six genes and was upregulated in nonresponders to anti-TNF therapy of five independent cohorts (n = 163), indicating acceptable discrimination ability (area under the receiver operating characteristic curve of 75-86%).</p><p><strong>Conclusions: </strong>The differences in gene expression and cellular composition between CD patients and non-CD controls imply significant molecular alterations, which are associated with the response to anti-TNF treatment.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the effects of a new transdermal formulation of systemic diclofenac on the upper gastrointestinal mucosa in patients with low back pain: A comparative study with oral diclofenac 腰痛患者上消化道黏膜对全身性双氯芬酸新型透皮制剂影响的调查:与口服双氯芬酸的比较研究。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-26 DOI: 10.1111/jgh.16810
Hiroyuki Fukase, Seiji Futagami, Takatsugu Yamamoto, Tatsuhiro Masaoka, Takaaki Terahara, Koji Okawa, Yusuke Tanaka, Tsuyoshi Mita

Background and Aim

Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with gastrointestinal mucosal damage attributed to a topical effect of NSAIDs on the gastrointestinal mucosa after oral administration and cyclooxygenase-1 inhibition. Diclofenac sodium systemic patch (DSSP), a transdermal patch from which diclofenac sodium is absorbed through the skin to exert its effects through the circulating blood, is considered to reduce the occurrence of gastrointestinal mucosal damage compared with oral diclofenac. This study aimed to compare the effect of DSSP on the upper gastrointestinal mucosa with that of an orally administered diclofenac sodium tablet (DST).

Methods

This randomized, evaluator-blinded study included Japanese patients with low back pain (LBP). The patients were administered with either DSSP (150 mg/day) or DST (75 mg/day) for 2 weeks. The primary endpoint was the incidence of gastroduodenal ulcers and/or erosions on upper gastrointestinal endoscopy after the study treatment.

Results

Thirty patients each were randomly assigned to the DSSP and DST groups. The incidence of gastroduodenal ulcers and/or erosions was 26.7% and 86.2% in the DSSP and DST groups, respectively. The difference in the incidence was −59.5% (95% confidence interval: −77.0 to −34.6). No adverse events (AEs) were observed in the DSSP group, and 20.0% (6/30 patients) reported mild AEs in the DST group (excluding ulcers and erosions).

Conclusion

DSSP is associated with a lower risk of gastrointestinal mucosal damage than DST, which has the same active ingredient but uses a different route of administration, in patients with LBP.

背景和目的:非甾体抗炎药(NSAIDs)与胃肠道粘膜损伤有关,这归因于非甾体抗炎药口服后对胃肠道粘膜的局部作用以及环氧化酶-1抑制作用。双氯芬酸钠全身贴剂(DSSP)是一种透皮贴剂,双氯芬酸钠可通过皮肤吸收并通过血液循环发挥作用,与口服双氯芬酸相比,DSSP可减少胃肠道粘膜损伤的发生。本研究旨在比较 DSSP 与口服双氯芬酸钠片剂(DST)对上消化道粘膜的影响:这项随机、评估者盲法研究纳入了日本的腰背痛(LBP)患者。患者接受了为期两周的 DSSP(150 毫克/天)或 DST(75 毫克/天)治疗。主要终点是研究治疗后上消化道内镜检查中胃十二指肠溃疡和/或糜烂的发生率:30名患者被随机分配到DSSP组和DST组。DSSP组和DST组的胃十二指肠溃疡和/或糜烂发生率分别为26.7%和86.2%。发生率的差异为-59.5%(95% 置信区间:-77.0 至-34.6)。DSSP 组未观察到不良事件 (AE),DST 组有 20.0% (6/30 名患者)报告了轻度不良事件(不包括溃疡和糜烂):结论:在枸杞多糖症患者中,DSSP 与 DST 相比,胃肠道粘膜损伤的风险更低,DST 的活性成分相同,但给药途径不同。
{"title":"Investigation of the effects of a new transdermal formulation of systemic diclofenac on the upper gastrointestinal mucosa in patients with low back pain: A comparative study with oral diclofenac","authors":"Hiroyuki Fukase,&nbsp;Seiji Futagami,&nbsp;Takatsugu Yamamoto,&nbsp;Tatsuhiro Masaoka,&nbsp;Takaaki Terahara,&nbsp;Koji Okawa,&nbsp;Yusuke Tanaka,&nbsp;Tsuyoshi Mita","doi":"10.1111/jgh.16810","DOIUrl":"10.1111/jgh.16810","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aim</h3>\u0000 \u0000 <p>Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with gastrointestinal mucosal damage attributed to a topical effect of NSAIDs on the gastrointestinal mucosa after oral administration and cyclooxygenase-1 inhibition. Diclofenac sodium systemic patch (DSSP), a transdermal patch from which diclofenac sodium is absorbed through the skin to exert its effects through the circulating blood, is considered to reduce the occurrence of gastrointestinal mucosal damage compared with oral diclofenac. This study aimed to compare the effect of DSSP on the upper gastrointestinal mucosa with that of an orally administered diclofenac sodium tablet (DST).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This randomized, evaluator-blinded study included Japanese patients with low back pain (LBP). The patients were administered with either DSSP (150 mg/day) or DST (75 mg/day) for 2 weeks. The primary endpoint was the incidence of gastroduodenal ulcers and/or erosions on upper gastrointestinal endoscopy after the study treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Thirty patients each were randomly assigned to the DSSP and DST groups. The incidence of gastroduodenal ulcers and/or erosions was 26.7% and 86.2% in the DSSP and DST groups, respectively. The difference in the incidence was −59.5% (95% confidence interval: −77.0 to −34.6). No adverse events (AEs) were observed in the DSSP group, and 20.0% (6/30 patients) reported mild AEs in the DST group (excluding ulcers and erosions).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>DSSP is associated with a lower risk of gastrointestinal mucosal damage than DST, which has the same active ingredient but uses a different route of administration, in patients with LBP.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":"39 12","pages":"2504-2510"},"PeriodicalIF":3.7,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgh.16810","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142729532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contamination of Disposable Distal Cap Duodenoscopes and Detachable Elevator Duodenoscopes After Reprocessing: A Randomized Trial. 一次性远端帽十二指肠镜和可拆卸升降十二指肠镜再处理后的污染:随机试验。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-25 DOI: 10.1111/jgh.16827
Wiriyaporn Ridtitid, Jirayus Buathong, Tanittha Chatsuwan, Phonthep Angsuwatcharakon, Thanawat Luangsukrerk, Parit Mekaroonkamol, Panida Piyachaturawat, Santi Kulpatcharapong, Pradermchai Kongkam, Rungsun Rerknimitr

Background and aim: To reduce bacterial contamination after reprocessing, various new designs of duodenoscopes have been developed to better expose the elevator complex for cleaning. We compared the rates of bacterial contamination and organic residue in disposable distal cap duodenoscopes and detachable elevator duodenoscopes after manual cleaning and high-level disinfection (HLD), as well as their cost-effectiveness.

Methods: A total of 162 duodenoscopes were randomly assigned to either Group A (disposable distal caps; n = 81) or Group B (detachable elevator; n = 81). A total of 324 samples from the elevator were collected for culture following manual cleaning (n = 81 in each group) and HLD (n = 81 in each group), followed by the adenosine triphosphate (ATP) testing for organic residue.

Results: After manual cleaning, there was no difference in bacterial contamination rates (8.6% vs. 8.6%; p = 1.00) and mean ATP levels (164.6 ± 257.5 vs. 158.1 ± 286.1 RLUs; p = 0.88) between Groups A and B. After HLD, no bacterial contamination was observed in either group and the mean ATP levels were very low with no significant difference between the two groups (30.1 ± 45.3 vs. 37.5 ± 51.9 RLUs; p = 0.68). The expense in reprocessing (excluding the scope cost) for Group A was lower (2099 USD) than Group B (3854 USD) in providing comparable scope cleanliness.

Conclusion: After manual cleaning, the bacterial contamination rate and organic residue levels in detachable elevator duodenoscopes and disposable distal caps duodenoscopes were comparable. No bacterial contamination was detected in either type of duodenoscope after reprocessing. Apart from the initial differences in scope cost, the disposable distal cap duodenoscope had lower cost on disposable items to have comparable disinfection result.

背景和目的:为了减少再处理后的细菌污染,人们开发了各种新型设计的十二指肠镜,以便更好地暴露升降器复合体进行清洁。我们比较了一次性远端帽十二指肠镜和可拆卸升降式十二指肠镜在人工清洗和高水平消毒(HLD)后的细菌污染率和有机残留率,以及它们的成本效益:共有162个十二指肠镜被随机分配到A组(一次性远端帽;n = 81)或B组(可拆卸升降器;n = 81)。在人工清洗(每组 81 人)和 HLD(每组 81 人)后,从升降器上共采集 324 份样本进行培养,然后进行三磷酸腺苷 (ATP) 有机残留物检测:人工清洗后,A 组和 B 组的细菌污染率(8.6% 对 8.6%;p = 1.00)和 ATP 平均水平(164.6 ± 257.5 对 158.1 ± 286.1 RLUs;p = 0.88)没有差异。在提供可比镜片清洁度的情况下,A 组的再处理费用(不包括镜片成本)(2099 美元)低于 B 组(3854 美元):人工清洁后,可拆卸升降式十二指肠镜和一次性远端帽十二指肠镜的细菌污染率和有机残留物水平相当。两种十二指肠镜在重新处理后都没有发现细菌污染。除了最初的镜片成本差异外,一次性远端帽十二指肠镜的一次性项目成本较低,消毒效果相当。
{"title":"Contamination of Disposable Distal Cap Duodenoscopes and Detachable Elevator Duodenoscopes After Reprocessing: A Randomized Trial.","authors":"Wiriyaporn Ridtitid, Jirayus Buathong, Tanittha Chatsuwan, Phonthep Angsuwatcharakon, Thanawat Luangsukrerk, Parit Mekaroonkamol, Panida Piyachaturawat, Santi Kulpatcharapong, Pradermchai Kongkam, Rungsun Rerknimitr","doi":"10.1111/jgh.16827","DOIUrl":"https://doi.org/10.1111/jgh.16827","url":null,"abstract":"<p><strong>Background and aim: </strong>To reduce bacterial contamination after reprocessing, various new designs of duodenoscopes have been developed to better expose the elevator complex for cleaning. We compared the rates of bacterial contamination and organic residue in disposable distal cap duodenoscopes and detachable elevator duodenoscopes after manual cleaning and high-level disinfection (HLD), as well as their cost-effectiveness.</p><p><strong>Methods: </strong>A total of 162 duodenoscopes were randomly assigned to either Group A (disposable distal caps; n = 81) or Group B (detachable elevator; n = 81). A total of 324 samples from the elevator were collected for culture following manual cleaning (n = 81 in each group) and HLD (n = 81 in each group), followed by the adenosine triphosphate (ATP) testing for organic residue.</p><p><strong>Results: </strong>After manual cleaning, there was no difference in bacterial contamination rates (8.6% vs. 8.6%; p = 1.00) and mean ATP levels (164.6 ± 257.5 vs. 158.1 ± 286.1 RLUs; p = 0.88) between Groups A and B. After HLD, no bacterial contamination was observed in either group and the mean ATP levels were very low with no significant difference between the two groups (30.1 ± 45.3 vs. 37.5 ± 51.9 RLUs; p = 0.68). The expense in reprocessing (excluding the scope cost) for Group A was lower (2099 USD) than Group B (3854 USD) in providing comparable scope cleanliness.</p><p><strong>Conclusion: </strong>After manual cleaning, the bacterial contamination rate and organic residue levels in detachable elevator duodenoscopes and disposable distal caps duodenoscopes were comparable. No bacterial contamination was detected in either type of duodenoscope after reprocessing. Apart from the initial differences in scope cost, the disposable distal cap duodenoscope had lower cost on disposable items to have comparable disinfection result.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron and Inflammatory Cytokines Synergistically Induce Colonic Epithelial Cell Ferroptosis in Colitis. 铁和炎症细胞因子协同诱导结肠炎中的结肠上皮细胞铁突变。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-25 DOI: 10.1111/jgh.16826
Mo Wang, Chang Zheng, Fan Zhou, Xie Ying, Xiaoqi Zhang, Chunyan Peng, Lei Wang

Inflammatory bowel disease (IBD) is an inflammatory disease that occurs to the intestinal tract. Many patients with IBD often develop anemia and often receive oral iron supplementation. Many of them develop non-compliance with oral iron therapy, but the mechanisms are not well understood. We interrogated whether colonic epithelial iron overload impacts cell viability and disease severity. We observed increased expression of iron importers and iron accumulation in mature colonocytes in dextran sulfate sodium (DSS)-induced acute colitis and in humans with active colitis. Administration of hepcidin increased epithelial iron overload and aggravated colonic inflammation in DSS-treated mice and IL10-/- mice. Hepcidin-induced iron accumulation increased colonic epithelial death, which was prevented by treatment with Trolox, a vitamin E analog and a scavenger of lipid peroxides. By using cultured Caco-2 cells, we showed that iron and inflammatory cytokines (TNF-α and IL-1β) induced a synergistic increase in the number of necrotic cells. We then showed that the combined treatment by hepcidin and cytokines increased labile iron content and lipid peroxidation in Caco-2 cells. Moreover, liproxstatin-1, a ferroptosis inhibitor, and deferoxamine, an iron chelator, both abolished the hepcidin/cytokines induced death of Caco-2 cells, suggesting ferroptosis. We further elucidated that inflammatory cytokines promote lipid peroxidation and ferroptosis by inducing NOX1-dependent exhaustion of reduced glutathione (GSH). Collectively, our findings demonstrate that the inflammatory context predisposes colonic epithelial cells to iron overload mediated ferroptosis, exacerbating colonic inflammation.

炎症性肠病(IBD)是一种发生在肠道的炎症性疾病。许多 IBD 患者经常会出现贫血,并经常接受口服铁剂补充治疗。他们中的许多人对口服铁剂治疗产生了不依从性,但其机制尚不十分清楚。我们研究了结肠上皮铁超载是否会影响细胞活力和疾病严重程度。在右旋糖酐硫酸钠(DSS)诱导的急性结肠炎和活动性结肠炎患者中,我们观察到成熟结肠细胞中铁导入因子的表达和铁积累增加。在经右旋糖酐硫酸钠(DSS)处理的小鼠和 IL10-/- 小鼠中,给予肝磷脂增加了上皮铁超载并加重了结肠炎症。用维生素 E 类似物和脂质过氧化物清除剂 Trolox 处理可防止这种情况。通过使用培养的 Caco-2 细胞,我们发现铁和炎症细胞因子(TNF-α 和 IL-1β)能协同增加坏死细胞的数量。我们随后发现,血红素和细胞因子的联合处理增加了 Caco-2 细胞中的可变铁含量和脂质过氧化反应。此外,铁螯合抑制剂 liproxstatin-1 和铁螯合剂 deferoxamine 都能抑制肝磷脂素/细胞因子诱导的 Caco-2 细胞死亡,这表明存在铁螯合作用。我们进一步阐明,炎性细胞因子通过诱导 NOX1 依赖性耗竭还原型谷胱甘肽(GSH)来促进脂质过氧化和铁变态反应。总之,我们的研究结果表明,炎症环境易使结肠上皮细胞发生铁超载介导的铁猝灭,从而加剧结肠炎症。
{"title":"Iron and Inflammatory Cytokines Synergistically Induce Colonic Epithelial Cell Ferroptosis in Colitis.","authors":"Mo Wang, Chang Zheng, Fan Zhou, Xie Ying, Xiaoqi Zhang, Chunyan Peng, Lei Wang","doi":"10.1111/jgh.16826","DOIUrl":"https://doi.org/10.1111/jgh.16826","url":null,"abstract":"<p><p>Inflammatory bowel disease (IBD) is an inflammatory disease that occurs to the intestinal tract. Many patients with IBD often develop anemia and often receive oral iron supplementation. Many of them develop non-compliance with oral iron therapy, but the mechanisms are not well understood. We interrogated whether colonic epithelial iron overload impacts cell viability and disease severity. We observed increased expression of iron importers and iron accumulation in mature colonocytes in dextran sulfate sodium (DSS)-induced acute colitis and in humans with active colitis. Administration of hepcidin increased epithelial iron overload and aggravated colonic inflammation in DSS-treated mice and IL10<sup>-/-</sup> mice. Hepcidin-induced iron accumulation increased colonic epithelial death, which was prevented by treatment with Trolox, a vitamin E analog and a scavenger of lipid peroxides. By using cultured Caco-2 cells, we showed that iron and inflammatory cytokines (TNF-α and IL-1β) induced a synergistic increase in the number of necrotic cells. We then showed that the combined treatment by hepcidin and cytokines increased labile iron content and lipid peroxidation in Caco-2 cells. Moreover, liproxstatin-1, a ferroptosis inhibitor, and deferoxamine, an iron chelator, both abolished the hepcidin/cytokines induced death of Caco-2 cells, suggesting ferroptosis. We further elucidated that inflammatory cytokines promote lipid peroxidation and ferroptosis by inducing NOX1-dependent exhaustion of reduced glutathione (GSH). Collectively, our findings demonstrate that the inflammatory context predisposes colonic epithelial cells to iron overload mediated ferroptosis, exacerbating colonic inflammation.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Impact of a Structured Capsule Endoscopy Training Program Using a New Validated Assessment Tool. 使用新型验证评估工具评估结构化胶囊内镜培训计划的影响。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-25 DOI: 10.1111/jgh.16823
Tiago Lima Capela, João Carlos Gonçalves, Ana Isabel Ferreira, Vítor Macedo Silva, Cláudia Macedo, Cátia Arieira, Sofia Xavier, Tiago Cúrdia Gonçalves, Pedro Boal Carvalho, Francisca Dias de Castro, Joana Magalhães, Bruno Rosa, Maria João Moreira, José Cotter

Background and aim: We aimed to develop and validate a simple capsule endoscopy (CE) training assessment tool, the Capsule Endoscopy Training Assessment (CETA), and prospectively use it to analyze the learning progression achieved by participants in our CE training program.

Methods: Over a 3-year period, all participants in our CE training program completed pre-training and post-training CETA, ranging between 0% and 100%, and encompassing theoretical questions and interpretation of segmented CE videos. We compared the mean differences in overall, theoretical, and practical pre-training and post-training CETA, and assessed the influence of previous endoscopic experience (upper gastrointestinal endoscopy [UGE], colonoscopy, device-assisted enteroscopy [DAE] and CE) using generalized linear models.

Results: Fifty-seven participants were included. After training, there was a significant increase in participants' overall (mean difference, 26.3; 95% confidence interval [CI], 20.70 to 31.83), theoretical (mean difference, 27.2; 95% CI, 19.81 to 34.57), and practical (mean difference, 25.9; 95% CI, 20.09 to 31.63) CETA components. Compared to those without experience, participants with previous endoscopic experience demonstrated a smaller increase in overall CETA after training (UGE, rate ratio, 0.76; 95% CI, 0.63 to 0.91; colonoscopy (rate ratio, 0.80; 95% CI, 0.67 to 0.95; DAE (rate ratio, 0.84; 95% CI, 0.73 to 0.97; CE, rate ratio, 0.81; 95% CI, 0.72 to 0.92, respectively).

Conclusion: CETA is a valid and useful tool in assessing the learning progression achieved by participants following the CE training program. We demonstrated a significant improvement in participants' CETA after training, being the least experienced participants in endoscopic procedures who benefited the most from CE training.

背景和目的:我们的目的是开发和验证一种简单的胶囊内镜(CE)培训评估工具--胶囊内镜培训评估(CETA),并用它来分析参加我们CE培训项目的学员的学习进度:在为期 3 年的时间里,我们 CE 培训项目的所有参与者都完成了培训前和培训后的 CETA,CETA 的范围从 0% 到 100% 不等,包括理论问题和分段 CE 视频的解读。我们比较了培训前和培训后CETA在总体、理论和实践方面的平均差异,并使用广义线性模型评估了以往内镜经验(上消化道内镜检查[UTE]、结肠镜检查、设备辅助肠镜检查[DAE]和CE)的影响:结果:57 名学员参加了培训。培训后,学员的总体(平均差异为 26.3;95% 置信区间 [CI],20.70 至 31.83)、理论(平均差异为 27.2;95% 置信区间 [CI],19.81 至 34.57)和实践(平均差异为 25.9;95% 置信区间 [CI],20.09 至 31.63)CETA 要素均有显著提高。与没有经验的学员相比,有过内窥镜检查经验的学员在培训后的总体 CETA 提高幅度较小(UGE,比率比为 0.76;95% CI,0.63 至 0.91;结肠镜检查,比率比为 0.80;95% CI,0.67 至 0.95;DAE,比率比为 0.84;95% CI,0.73 至 0.97;CE,比率比为 0.81;95% CI,0.72 至 0.92):CETA是一种有效且实用的工具,可用于评估参加 CE 培训项目的学员的学习进度。我们的研究表明,培训后学员的 CETA 有了明显提高,内镜手术经验最浅的学员从 CE 培训中获益最多。
{"title":"Assessing the Impact of a Structured Capsule Endoscopy Training Program Using a New Validated Assessment Tool.","authors":"Tiago Lima Capela, João Carlos Gonçalves, Ana Isabel Ferreira, Vítor Macedo Silva, Cláudia Macedo, Cátia Arieira, Sofia Xavier, Tiago Cúrdia Gonçalves, Pedro Boal Carvalho, Francisca Dias de Castro, Joana Magalhães, Bruno Rosa, Maria João Moreira, José Cotter","doi":"10.1111/jgh.16823","DOIUrl":"https://doi.org/10.1111/jgh.16823","url":null,"abstract":"<p><strong>Background and aim: </strong>We aimed to develop and validate a simple capsule endoscopy (CE) training assessment tool, the Capsule Endoscopy Training Assessment (CETA), and prospectively use it to analyze the learning progression achieved by participants in our CE training program.</p><p><strong>Methods: </strong>Over a 3-year period, all participants in our CE training program completed pre-training and post-training CETA, ranging between 0% and 100%, and encompassing theoretical questions and interpretation of segmented CE videos. We compared the mean differences in overall, theoretical, and practical pre-training and post-training CETA, and assessed the influence of previous endoscopic experience (upper gastrointestinal endoscopy [UGE], colonoscopy, device-assisted enteroscopy [DAE] and CE) using generalized linear models.</p><p><strong>Results: </strong>Fifty-seven participants were included. After training, there was a significant increase in participants' overall (mean difference, 26.3; 95% confidence interval [CI], 20.70 to 31.83), theoretical (mean difference, 27.2; 95% CI, 19.81 to 34.57), and practical (mean difference, 25.9; 95% CI, 20.09 to 31.63) CETA components. Compared to those without experience, participants with previous endoscopic experience demonstrated a smaller increase in overall CETA after training (UGE, rate ratio, 0.76; 95% CI, 0.63 to 0.91; colonoscopy (rate ratio, 0.80; 95% CI, 0.67 to 0.95; DAE (rate ratio, 0.84; 95% CI, 0.73 to 0.97; CE, rate ratio, 0.81; 95% CI, 0.72 to 0.92, respectively).</p><p><strong>Conclusion: </strong>CETA is a valid and useful tool in assessing the learning progression achieved by participants following the CE training program. We demonstrated a significant improvement in participants' CETA after training, being the least experienced participants in endoscopic procedures who benefited the most from CE training.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
White-Light Imaging and Image-Enhanced Endoscopy With Magnifying Endoscopy for the Optical Diagnosis of Superficial Nonampullary Duodenal Epithelial Tumors: A Systematic Review and Meta-Analysis. 白光成像和图像增强内镜与放大内镜用于浅表非髓质十二指肠上皮肿瘤的光学诊断:系统回顾与元分析》。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-25 DOI: 10.1111/jgh.16822
Masao Yoshida, Yosuke Toya, Akifumi Notsu, Naomi Kakushima, Motohiko Kato, Naohisa Yahagi

Background and aim: Optical diagnosis of superficial nonampullary duodenal epithelial tumors using white-light imaging (WLI) and/or narrow-band imaging with magnifying endoscopy (NBI-ME) is used to guide the treatment strategy and avoid biopsy-induced fibrosis. However, the effectiveness of this approach has not been elucidated. We conducted a systematic review and meta-analysis aiming to investigate the diagnostic yield between Vienna classification category 3 (VCL C3) and categories 4 or 5 (VCL C4/C5) using biopsy, WLI, NBI-ME, and WLI + NBI-ME.

Methods: A literature search identified studies on the diagnosis of superficial nonampullary duodenal epithelial tumors using biopsy, WLI, or NBI-ME. A bivariate random-effects model was utilized to analyze the summary estimates of sensitivity and specificity, as well as the area under the summary receiver operating characteristic curves for diagnosing VCL C4/C5.

Results: Ultimately, 13 studies were included in the meta-analysis. For the diagnosis of VCL C4/C5, summary estimates of sensitivity, specificity, and area under the curve were for biopsy 47% (95% confidence interval: 37-58), 86% (79-91), and 0.745; for WLI 80% (65-89), 80% (70-87), and 0.859; for NBI-ME were 72% (61-81), 76% (68-85), and 0.811; and for WLI + NBI-ME 88% (67-96), 87% (51-98), and 0.929, respectively.

Conclusions: WLI, NBI-ME, and WLI + NBI-ME showed high values for sensitivity and area under the curve. Biopsies can be replaced by WLI, NBI-ME, and WLI + NBI-ME for the preoperative diagnosis of superficial nonampullary duodenal epithelial tumors. However, further accumulation of research findings is needed.

背景和目的:使用白光成像(WLI)和/或放大内镜窄带成像(NBI-ME)对浅表非髓质十二指肠上皮肿瘤进行光学诊断,可用于指导治疗策略并避免活检引起的纤维化。然而,这种方法的有效性尚未得到阐明。我们进行了一项系统回顾和荟萃分析,旨在研究维也纳分类 3 类(VCL C3)与 4 类或 5 类(VCL C4/C5)之间使用活检、WLI、NBI-ME 和 WLI + NBI-ME 的诊断率:文献检索确定了使用活检、WLI 或 NBI-ME 诊断浅表非髓质十二指肠上皮肿瘤的研究。利用双变量随机效应模型分析了诊断 VCL C4/C5 的灵敏度和特异性的汇总估计值以及接收者操作特征曲线下的面积:荟萃分析最终纳入了 13 项研究。对于 VCL C4/C5 的诊断,活检的敏感性、特异性和曲线下面积的汇总估计值分别为 47%(95% 置信区间:37-58)、86%(79-91)和 0.745;WLI 为 80%(65-89)、80%(70-87)和 0.859;NBI-ME 分别为 72%(61-81)、76%(68-85)和 0.811;WLI + NBI-ME 分别为 88%(67-96)、87%(51-98)和 0.929:WLI、NBI-ME和WLI + NBI-ME显示出较高的灵敏度和曲线下面积。在浅表非髓质十二指肠上皮肿瘤的术前诊断中,WLI、NBI-ME 和 WLI + NBI-ME 可以取代活组织检查。不过,还需要进一步积累研究成果。
{"title":"White-Light Imaging and Image-Enhanced Endoscopy With Magnifying Endoscopy for the Optical Diagnosis of Superficial Nonampullary Duodenal Epithelial Tumors: A Systematic Review and Meta-Analysis.","authors":"Masao Yoshida, Yosuke Toya, Akifumi Notsu, Naomi Kakushima, Motohiko Kato, Naohisa Yahagi","doi":"10.1111/jgh.16822","DOIUrl":"https://doi.org/10.1111/jgh.16822","url":null,"abstract":"<p><strong>Background and aim: </strong>Optical diagnosis of superficial nonampullary duodenal epithelial tumors using white-light imaging (WLI) and/or narrow-band imaging with magnifying endoscopy (NBI-ME) is used to guide the treatment strategy and avoid biopsy-induced fibrosis. However, the effectiveness of this approach has not been elucidated. We conducted a systematic review and meta-analysis aiming to investigate the diagnostic yield between Vienna classification category 3 (VCL C3) and categories 4 or 5 (VCL C4/C5) using biopsy, WLI, NBI-ME, and WLI + NBI-ME.</p><p><strong>Methods: </strong>A literature search identified studies on the diagnosis of superficial nonampullary duodenal epithelial tumors using biopsy, WLI, or NBI-ME. A bivariate random-effects model was utilized to analyze the summary estimates of sensitivity and specificity, as well as the area under the summary receiver operating characteristic curves for diagnosing VCL C4/C5.</p><p><strong>Results: </strong>Ultimately, 13 studies were included in the meta-analysis. For the diagnosis of VCL C4/C5, summary estimates of sensitivity, specificity, and area under the curve were for biopsy 47% (95% confidence interval: 37-58), 86% (79-91), and 0.745; for WLI 80% (65-89), 80% (70-87), and 0.859; for NBI-ME were 72% (61-81), 76% (68-85), and 0.811; and for WLI + NBI-ME 88% (67-96), 87% (51-98), and 0.929, respectively.</p><p><strong>Conclusions: </strong>WLI, NBI-ME, and WLI + NBI-ME showed high values for sensitivity and area under the curve. Biopsies can be replaced by WLI, NBI-ME, and WLI + NBI-ME for the preoperative diagnosis of superficial nonampullary duodenal epithelial tumors. However, further accumulation of research findings is needed.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten-day versus 14-day vonoprazan-amoxicillin high-dose dual therapy for Helicobacter pylori eradication in China: A multicenter, open-label, randomized study 中国根除幽门螺旋杆菌的 10 天与 14 天 Vonoprazan-阿莫西林大剂量双重疗法:一项多中心、开放标签、随机研究。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-24 DOI: 10.1111/jgh.16761
Aiping Lin, Zhihui Lin, Yijuan Liu, Shuo Chen, Yanfeng Shao, Feng Qiu, Zhongqin Xiao, Zhangkun Xu, Longqun Chen, Lianghuo Chen, Weixing Lin, Yongfu Wang, Zhonghua Huang, Zhenqun Lin, Xueping Huang

Background and Aim

Only a few studies have investigated the efficacy and safety of different durations of vonoprazan and amoxicillin (VA) high-dose dual therapy for the eradication of Helicobacter pylori. We aimed to compare the efficacy and safety of 10 days versus 14 days of VA high-dose dual therapy for H. pylori eradication.

Methods

This study was conducted in 14 centers in China. A total of 250 patients infected with H. pylori were randomly assigned to Group VA-10 or VA-14. Both groups received the VA dual therapy (vonoprazan 20 mg twice daily + amoxicillin 1000 mg three times daily). The primary endpoint was the H. pylori eradication rate. Secondary endpoints included adverse events and patient compliance.

Results

Group VA-10 achieved eradication rates of 89.60%, 91.06%, and 91.67% as determined by the intention-to-treat (ITT), modified intention-to-treat (MITT), and per-protocol (PP) analysis, respectively. The eradication rates were similar to those in Group VA-14: 91.20%, 93.44%, and 93.39%. The difference and 90% confidence interval boundary −1.60% (−7.73% to 4.53%) in the ITT analysis, −2.39% (−8.00% to 3.23%) in the MITT analysis, and −1.72% (−7.29% to 3.85%) in the PP analysis were greater than the predefined noninferiority margin of −10%, establishing a noninferiority of Group VA-10 versus Group VA-14 (noninferiority P = 0.001 in ITT analysis, P < 0.001 in MITT analysis, and P < 0.001 in PP analysis, respectively). No significant differences were observed in adverse events between the two groups.

Conclusions

Ten-day VA dual therapy achieves comparable efficacy and safety to the 14-day regimen in Chinese population, providing patients with greater convenience and economic benefits.

背景和目的:只有少数研究调查了不同疗程的冯诺普拉赞和阿莫西林(VA)大剂量双重疗法根除幽门螺杆菌的疗效和安全性。我们旨在比较 10 天与 14 天 VA 大剂量双重疗法根除幽门螺杆菌的疗效和安全性:本研究在中国的 14 个中心进行。共有250名幽门螺杆菌感染者被随机分配到VA-10组或VA-14组。两组均接受 VA 双联疗法(沃诺普赞 20 毫克,每日两次;阿莫西林 1000 毫克,每日三次)。主要终点是幽门螺杆菌根除率。次要终点包括不良事件和患者依从性:根据意向治疗(ITT)、改良意向治疗(MITT)和每方案(PP)分析,VA-10 组的根除率分别为 89.60%、91.06% 和 91.67%。根除率与 VA-14 组相似:91.20%、93.44% 和 93.39%。ITT分析中的差值和90%置信区间边界为-1.60%(-7.73%至4.53%),MITT分析中的差值和90%置信区间边界为-2.39%(-8.00%至3.23%),PP分析中的差值和90%置信区间边界为-1.72%(-7.29%至3.85%),均大于预先设定的非劣效性边际-10%,从而确定了VA-10组与VA-14组的非劣效性(ITT分析中的非劣效性P = 0.001,P结论:在中国人群中,10 天 VA 双联疗法的疗效和安全性与 14 天疗法相当,为患者提供了更大的便利和经济效益。
{"title":"Ten-day versus 14-day vonoprazan-amoxicillin high-dose dual therapy for Helicobacter pylori eradication in China: A multicenter, open-label, randomized study","authors":"Aiping Lin,&nbsp;Zhihui Lin,&nbsp;Yijuan Liu,&nbsp;Shuo Chen,&nbsp;Yanfeng Shao,&nbsp;Feng Qiu,&nbsp;Zhongqin Xiao,&nbsp;Zhangkun Xu,&nbsp;Longqun Chen,&nbsp;Lianghuo Chen,&nbsp;Weixing Lin,&nbsp;Yongfu Wang,&nbsp;Zhonghua Huang,&nbsp;Zhenqun Lin,&nbsp;Xueping Huang","doi":"10.1111/jgh.16761","DOIUrl":"10.1111/jgh.16761","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aim</h3>\u0000 \u0000 <p>Only a few studies have investigated the efficacy and safety of different durations of vonoprazan and amoxicillin (VA) high-dose dual therapy for the eradication of <i>Helicobacter pylori</i>. We aimed to compare the efficacy and safety of 10 days <i>versus</i> 14 days of VA high-dose dual therapy for <i>H. pylori</i> eradication.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study was conducted in 14 centers in China. A total of 250 patients infected with <i>H. pylori</i> were randomly assigned to Group VA-10 or VA-14. Both groups received the VA dual therapy (vonoprazan 20 mg twice daily + amoxicillin 1000 mg three times daily). The primary endpoint was the <i>H. pylori</i> eradication rate. Secondary endpoints included adverse events and patient compliance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Group VA-10 achieved eradication rates of 89.60%, 91.06%, and 91.67% as determined by the intention-to-treat (ITT), modified intention-to-treat (MITT), and per-protocol (PP) analysis, respectively. The eradication rates were similar to those in Group VA-14: 91.20%, 93.44%, and 93.39%. The difference and 90% confidence interval boundary −1.60% (−7.73% to 4.53%) in the ITT analysis, −2.39% (−8.00% to 3.23%) in the MITT analysis, and −1.72% (−7.29% to 3.85%) in the PP analysis were greater than the predefined noninferiority margin of −10%, establishing a noninferiority of Group VA-10 <i>versus</i> Group VA-14 (noninferiority <i>P</i> = 0.001 in ITT analysis, <i>P</i> &lt; 0.001 in MITT analysis, and <i>P</i> &lt; 0.001 in PP analysis, respectively). No significant differences were observed in adverse events between the two groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Ten-day VA dual therapy achieves comparable efficacy and safety to the 14-day regimen in Chinese population, providing patients with greater convenience and economic benefits.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":"39 12","pages":"2645-2653"},"PeriodicalIF":3.7,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Lifestyles on Polyp Burden and Cancer Development in Hereditary Colorectal Cancer Syndromes. 生活方式对遗传性大肠癌综合征的息肉负担和癌症发展的影响
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-24 DOI: 10.1111/jgh.16833
Hye Kyung Hyun, Ji Soo Park, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim

Background: Whether the progression of precursor lesions or the occurrence of cancer is influenced by lifestyle factors in carriers of genetic mutations has not been fully investigated, especially in Asian patients of hereditary colorectal cancer (CRC) syndrome.

Methods: Patients at a high risk of hereditary CRC were included. For polyposis CRC syndromes, colorectal polyp burden was measured using at least 60 images per colonoscopy in each patient and classified into five stages using the International Society for Gastrointestinal Hereditary Tumours staging system according to the polyp number and size. Increase in tumor burden stage for polyposis CRC syndrome and the occurrence of CRC or any cancer for Lynch syndrome were analyzed according to lifestyle factors.

Results: Ninety-six patients with suspected hereditary polyposis CRC syndrome and 106 patients with Lynch syndrome were recruited. For polyposis CRC syndromes, multivariate analysis showed that exposure to smoking and > 100 polyps independently predicted a high risk of increased polyp burden (p = 0.008 and p = 0.012, respectively). Significant genetic mutations or phenotype of polyposis syndromes were significantly associated with an increased polyp burden. For Lynch syndrome, smokers showed to be diagnosed with CRC in younger age than never-smokers (42.2 years vs. 49.0 years; p = 0.021), and heavy drinkers had high risk for occurrence of CRC (HR, 2.381, 95% CI, 1.338-4.236; p = 0.003) and any cancer (HR, 2.254; 95% CI, 1.334-3.806; p = 0.002).

Conclusions: The lifestyle factors (smoking and alcohol consumption) were associated with increasing precursor lesions and occurrence of cancer in patients with hereditary CRC syndrome. Lifestyle modifications may reduce the risk of hereditary CRC in carriers.

背景:遗传突变携带者的前驱病变进展或癌症发生是否受生活方式因素的影响尚未得到充分研究,尤其是在遗传性结直肠癌(CRC)综合征的亚洲患者中:方法:纳入遗传性 CRC 高风险患者。对于息肉病 CRC 综合征,每位患者每次结肠镜检查至少使用 60 张图像测量结肠直肠息肉负荷,并使用国际胃肠道遗传性肿瘤学会分期系统根据息肉数量和大小将其分为五个阶段。根据生活方式因素分析了息肉病 CRC 综合征肿瘤负荷分期的增加情况,以及林奇综合征 CRC 或任何癌症的发生情况:结果:共招募了 96 名疑似遗传性息肉病 CRC 综合征患者和 106 名林奇综合征患者。对于息肉病 CRC 综合征,多变量分析表明,吸烟和息肉大于 100 个可独立预测息肉负担增加的高风险(分别为 p = 0.008 和 p = 0.012)。息肉病综合征的重大基因突变或表型与息肉负荷增加有显著相关性。就林奇综合征而言,吸烟者确诊为 CRC 的年龄比从不吸烟者小(42.2 岁对 49.0 岁;p = 0.021),而酗酒者患 CRC(HR,2.381,95% CI,1.338-4.236;p = 0.003)和任何癌症(HR,2.254;95% CI,1.334-3.806;p = 0.002)的风险高:结论:生活方式因素(吸烟和饮酒)与遗传性 CRC 综合征患者前体病变的增加和癌症的发生有关。改变生活方式可降低遗传性 CRC 携带者的风险。
{"title":"Influence of Lifestyles on Polyp Burden and Cancer Development in Hereditary Colorectal Cancer Syndromes.","authors":"Hye Kyung Hyun, Ji Soo Park, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim","doi":"10.1111/jgh.16833","DOIUrl":"https://doi.org/10.1111/jgh.16833","url":null,"abstract":"<p><strong>Background: </strong>Whether the progression of precursor lesions or the occurrence of cancer is influenced by lifestyle factors in carriers of genetic mutations has not been fully investigated, especially in Asian patients of hereditary colorectal cancer (CRC) syndrome.</p><p><strong>Methods: </strong>Patients at a high risk of hereditary CRC were included. For polyposis CRC syndromes, colorectal polyp burden was measured using at least 60 images per colonoscopy in each patient and classified into five stages using the International Society for Gastrointestinal Hereditary Tumours staging system according to the polyp number and size. Increase in tumor burden stage for polyposis CRC syndrome and the occurrence of CRC or any cancer for Lynch syndrome were analyzed according to lifestyle factors.</p><p><strong>Results: </strong>Ninety-six patients with suspected hereditary polyposis CRC syndrome and 106 patients with Lynch syndrome were recruited. For polyposis CRC syndromes, multivariate analysis showed that exposure to smoking and > 100 polyps independently predicted a high risk of increased polyp burden (p = 0.008 and p = 0.012, respectively). Significant genetic mutations or phenotype of polyposis syndromes were significantly associated with an increased polyp burden. For Lynch syndrome, smokers showed to be diagnosed with CRC in younger age than never-smokers (42.2 years vs. 49.0 years; p = 0.021), and heavy drinkers had high risk for occurrence of CRC (HR, 2.381, 95% CI, 1.338-4.236; p = 0.003) and any cancer (HR, 2.254; 95% CI, 1.334-3.806; p = 0.002).</p><p><strong>Conclusions: </strong>The lifestyle factors (smoking and alcohol consumption) were associated with increasing precursor lesions and occurrence of cancer in patients with hereditary CRC syndrome. Lifestyle modifications may reduce the risk of hereditary CRC in carriers.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PANoptosis-related genes: Molecular insights into immune dysregulation in ulcerative colitis. PANoptosis 相关基因:溃疡性结肠炎免疫调节失调的分子见解。
IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-20 DOI: 10.1111/jgh.16804
Yuxiao Ji, Pengchong Li, Tingting Ning, Deyi Yang, Haiyun Shi, Xueyu Dong, Shengtao Zhu, Peng Li, Shutian Zhang

Background and aim: Ulcerative colitis (UC) is a chronic inflammatory disease driven by immune dysregulation. PANoptosis, a novel form of programmed cell death, has been implicated in inflammatory diseases, but its specific role in UC remains unclear. This study aimed to identify PANoptosis-related genes (PRGs) that may contribute to immune dysregulation in UC.

Methods: Using bioinformatics analysis of the GEO databases, we identified seven hub PRGs. Based on these genes, we developed a predictive model to differentiate UC patients from healthy controls, and evaluated its diagnostic performance using ROC curve analysis. We further conducted functional enrichment, GSVA, and immune infiltration analyses. Immunohistochemistry (IHC) was used to validate the expression of hub genes in UC patients.

Results: The prediction model, based on the seven hub genes, exhibited diagnostic ability in discriminating UC patients from controls. Furthermore, these hub PRGs were found to be associated with immune cells, including dendritic cells, NK cells, macrophages, regulatory T cells (Tregs), and CD8+ T cells. They were also linked to key signaling pathways implicated in UC pathogenesis, such as IFNγ, TNFα, IL6-and JAK-STAT3, as well as hypoxia and apoptosis. Immunohistochemistry analysis validated the expression levels of hub PRGs in UC patients using paraffin sections of intestinal biopsy specimens.

Conclusions: This study identified PANoptosis-related genes with potential diagnostic value for UC and suggest that PANoptosis may contribute to the pathogenesis of UC by regulating specific immune cells and interacting with key signaling pathways. This highlights the potential importance of PANoptosis-related genes as therapeutic targets in UC management.

背景和目的:溃疡性结肠炎(UC)是一种由免疫失调引起的慢性炎症性疾病。细胞凋亡(PANoptosis)是一种新型的程序性细胞死亡形式,已被认为与炎症性疾病有关,但其在 UC 中的具体作用仍不清楚。本研究旨在鉴定可能导致 UC 免疫失调的 PANoptosis 相关基因(PRGs):方法:通过对 GEO 数据库进行生物信息学分析,我们确定了七个枢纽 PRGs。在这些基因的基础上,我们建立了一个用于区分 UC 患者和健康对照的预测模型,并利用 ROC 曲线分析评估了该模型的诊断性能。我们进一步进行了功能富集、GSVA 和免疫浸润分析。免疫组织化学(IHC)用于验证 UC 患者中枢基因的表达:结果:基于七个枢纽基因的预测模型在区分 UC 患者和对照组方面表现出了诊断能力。此外,还发现这些中心基因与免疫细胞有关,包括树突状细胞、NK细胞、巨噬细胞、调节性T细胞(Tregs)和CD8+T细胞。它们还与涉及 UC 发病机制的关键信号通路有关,如 IFNγ、TNFα、IL6 和 JAK-STAT3,以及缺氧和细胞凋亡。免疫组化分析利用石蜡切片肠活检标本验证了 UC 患者中枢 PRGs 的表达水平:本研究发现了与 PANoptosis 相关的基因,这些基因对 UC 具有潜在的诊断价值,并提示 PANoptosis 可能通过调节特定的免疫细胞并与关键信号通路相互作用,从而促进 UC 的发病机制。这凸显了 PANoptosis 相关基因作为 UC 治疗靶点的潜在重要性。
{"title":"PANoptosis-related genes: Molecular insights into immune dysregulation in ulcerative colitis.","authors":"Yuxiao Ji, Pengchong Li, Tingting Ning, Deyi Yang, Haiyun Shi, Xueyu Dong, Shengtao Zhu, Peng Li, Shutian Zhang","doi":"10.1111/jgh.16804","DOIUrl":"https://doi.org/10.1111/jgh.16804","url":null,"abstract":"<p><strong>Background and aim: </strong>Ulcerative colitis (UC) is a chronic inflammatory disease driven by immune dysregulation. PANoptosis, a novel form of programmed cell death, has been implicated in inflammatory diseases, but its specific role in UC remains unclear. This study aimed to identify PANoptosis-related genes (PRGs) that may contribute to immune dysregulation in UC.</p><p><strong>Methods: </strong>Using bioinformatics analysis of the GEO databases, we identified seven hub PRGs. Based on these genes, we developed a predictive model to differentiate UC patients from healthy controls, and evaluated its diagnostic performance using ROC curve analysis. We further conducted functional enrichment, GSVA, and immune infiltration analyses. Immunohistochemistry (IHC) was used to validate the expression of hub genes in UC patients.</p><p><strong>Results: </strong>The prediction model, based on the seven hub genes, exhibited diagnostic ability in discriminating UC patients from controls. Furthermore, these hub PRGs were found to be associated with immune cells, including dendritic cells, NK cells, macrophages, regulatory T cells (Tregs), and CD8+ T cells. They were also linked to key signaling pathways implicated in UC pathogenesis, such as IFNγ, TNFα, IL6-and JAK-STAT3, as well as hypoxia and apoptosis. Immunohistochemistry analysis validated the expression levels of hub PRGs in UC patients using paraffin sections of intestinal biopsy specimens.</p><p><strong>Conclusions: </strong>This study identified PANoptosis-related genes with potential diagnostic value for UC and suggest that PANoptosis may contribute to the pathogenesis of UC by regulating specific immune cells and interacting with key signaling pathways. This highlights the potential importance of PANoptosis-related genes as therapeutic targets in UC management.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Gastroenterology and Hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1